Results 11 to 20 of about 836,777 (260)

Pancreatic Divisum Associated with Ampullary Neuroendocrine Tumor and the Role of Magnetic Resonance Imaging

Haseki Tıp Bülteni, 2017
Pancreatic divisum is the most common anomaly of the pancreas. Pancreatic divisum associated with malignant tumor is rarely seen. The ampulla of Vater is formed by the union of the common bile duct and the pancreatic duct.
Fatma Kulalı, Aslıhan Semiz Oysu, Yaşar Bükte   +2 more
doaj   +2 more sources

Biomarkers in Pancreatic Neuroendocrine Tumors [PDF]

JOP : Journal of the pancreas, 2014
The aim of biomarkers is to identify patients most likely to benefit from a therapeutic strategy. Pancreatic neuroendocrine tumors are rare neoplasms that arise in the endocrine tissues of the pancreas. Pancreatic neuroendocrine tumors represent 3% of primary pancreatic neoplasms and their incidence has risen.
Maria Serafeim, Theochari, Konstantinos N, Syrigos, Muhammad Wasif, Saif   +2 more
openaire   +3 more sources

Predicting Factor for Occurrence of Postoperative Pancreatic Fistula in Patients with Pancreatic Neuroendocrine Tumors

Diagnostics
Background: Neuroendocrine tumors are tumors that can develop in any organ but show a predilection for the pancreas. These can be secreting or non-secreting tumors, or they can be well differentiated or poorly differentiated, or neuroendocrine carcinomas.
Nutu Vlad, Florina Delia Andriesi-Rusu, Andrei Chicos, Ana Maria Trofin, Ramona Cadar, Mihai Lucian Zabara, Delia Ciobanu, Mircea Costache, Corina Lupascu-Ursulescu, Alin Mihai Vasilescu, Costel Bradea, Mihaela Blaj, Oana Maria Lovin, Adi Ionut Ciumanghel, Felicia Crumpei, Cristian Dumitru Lupascu   +15 more
doaj   +2 more sources

Everolimus and mTOR inhibition in pancreatic neuroendocrine tumors

Cancer Management and Research, 2012
Kein-Leong YimVelindre Cancer Center, Cardiff, Wales, United KingdomAbstract: Pancreatic neuroendocrine tumors are rare and the majority of patients present in the advanced stage. Over the past few decades, treatment for patients with metastatic well- or
Yim K-L
doaj   +1 more source

Expression studies on PPARγ in pancreatic neuroendocrine tumours [PDF]

, 2010
MDPancreatic NETs occur with an annual incidence of around 5 per 1,000,000 population per year, with survival rates of between 30 – 97% at 5 years depending on the tumour subtype.
Hanson, Matthew Richard
core   +4 more sources

Pancreatic neuroendocrine tumors [PDF]

Current Opinion in Gastroenterology, 2019
Pancreatic neuroendocrine tumors (pNETs) are a rare, heterogeneous group of pancreatic neoplasms with a wide range of malignant potential. They may manifest as noninfiltrative, slow-growing tumors, locally invasive masses, or even swiftly metastasizing cancers.In recent years, because of the increasing amount of scientific literature available for ...
Perri G., Prakash L. R., Katz M. H. G.
openaire   +3 more sources

DNA methylation reveals distinct cells of origin for pancreatic neuroendocrine carcinomas and pancreatic neuroendocrine tumors. [PDF]

, 2022
BACKGROUND Pancreatic neuroendocrine neoplasms (PanNENs) fall into two subclasses: the well-differentiated, low- to high-grade pancreatic neuroendocrine tumors (PanNETs), and the poorly-differentiated, high-grade pancreatic neuroendocrine carcinomas ...
Khouja, Slim, Bormann, Felix, Riemer, Pamela, Jarosch, Armin, Lenze, Dido, Horst, David, Marinoni, Ilaria, Detjen, Katharina, Rossner, Florian, Menne, Andrea, Childs, Liam H, Mamlouk, Soulafa, Simon, Tincy, Childs, Liam H., Blüthgen, Nils, Sers, Christine, Domenico, Annunziata Di, Di Domenico, Annunziata, Leser, Ulf, Monjé, Nanna, Pavel, Marianne, Capper, David, Morkel, Markus, Perren, Aurel   +23 more
core   +2 more sources

Application of Radiomics Analysis Based on CT Combined With Machine Learning in Diagnostic of Pancreatic Neuroendocrine Tumors Patient’s Pathological Grades

Frontiers in Oncology, 2021
PurposeTo evaluate the value of multiple machine learning methods in classifying pathological grades (G1,G2, and G3), and to provide the best machine learning method for the identification of pathological grades of pancreatic neuroendocrine tumors (PNETs)
Tao Zhang, Tao Zhang, YueHua Zhang, Xinglong Liu, Hanyue Xu, Chaoyue Chen, Xuan Zhou, Yichun Liu, Xuelei Ma, Xuelei Ma   +9 more
doaj   +1 more source

Total Pancreatectomy for Multicentric Cystic Neuroendocrine Tumor of the Pancreas: A Case Report

Diagnostics, 2022
Pancreatic neuroendocrine tumors (PNETs) are uncommon pancreatic neoplasms with malignant potential, heterogeneous clinical behavior, as well as imaging appearance.
Milica Mitrovic-Jovanovic, Nikica Grubor, Stefan Milosevic, Aleksandra Jankovic, Katarina Stosic, Slavenko Ostojic, Aleksandar Ninic, Marjan Micev, Jelena Djokic Kovac   +8 more
doaj   +1 more source

Pancreatic mixed acinar-neuroendocrine carcinoma with intraductal growth: A case report with radiologic–pathologic correlations

Radiology Case Reports, 2023
Pancreatic mixed acinar-neuroendocrine carcinomas are rare malignant tumors of the pancreas. They are composed histologically of both acinar and neuroendocrine cells.
Hiroshi Baba, MD, Yasunari Yamada, MD, Kazuhiro Tada, MD, Yusuke Kuboyama, MD, Kengo Fukuzawa, MD, Kentaro Iwaki, MD, Mitsuteru Motomura, MD, Ryo Takaji, MD, Ryuichi Shimada, MD, Hajime Takaki, MD, Yoshiki Asayama, MD   +10 more
doaj   +1 more source